Literature DB >> 1100533

Chronic cerebral effects of alcohol and drug abuse.

I Grant, L Mohns.   

Abstract

A minority of alcohol abusers develop severe cerebral dysfunction in the form of Wernicke-Korsakoff syndrome. There is also evidence to suggest that cerebral dysfunction, particularly impaired abstracting ability, occurs in that larger population of heavy drinkers who do not go on to develop the Wernicke-Korsakoff syndrome. There is no consistent evidence that long-term marijuana, hallucinogen, or sedative use causes lasting neuropsychological disturbance. The deficits in abstract thinking reported by some LSD studies are similar to deficits others have reported among alcoholics. Since the LSD studies were not controlled for alcohol use, their interpretation is difficult. It appears that cerebrovascular accidents occur more frequently and at a younger age among amphetamine abusers. There is no reliable information about possible other long-term effects of stimulants on the brain per se (i.e., nonvascular complications). Abuse of intravenous narcotics has been associated with case reports of transverse myelitis and encephalitis. It is not known whether this pathology is a direct or hypersensitivity effect of narcotic drugs, of adulterants, or of infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100533     DOI: 10.3109/10826087509027346

Source DB:  PubMed          Journal:  Int J Addict        ISSN: 0020-773X


  3 in total

1.  Alcohol attentional bias: drinking salience or cognitive impairment?

Authors:  Javad Salehi Fadardi; W Miles Cox
Journal:  Psychopharmacology (Berl)       Date:  2006-02-21       Impact factor: 4.530

2.  A behavior profile of polydrug abusers.

Authors:  B Kennedy; M Konstantareas; S Homatidis
Journal:  J Youth Adolesc       Date:  1987-04

3.  Volumetric brain abnormalities in polysubstance use disorder patients.

Authors:  Cemal Onur Noyan; Samet Kose; Serdar Nurmedov; Baris Metin; Aslı Enez Darcin; Nesrin Dilbaz
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-13       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.